Sanja Ledinski Ficko, Vlatko Pejsa and Vesna Zadnik
Oncol 1998; 16: 1188-96. doi: 10.1200/JCO.19184.108.40.2068 10.1200/JCO.19220.127.116.118 9508207
Hjermstad MJ Fayers PM Bjordal K Kaasa S Health related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality –of-Life Questionnaire: The QLQ=C30 (+3) J Clin Oncol 1998 16 1188 96 10.1200/JCO.1918.104.22.1688
26 Ministry of Regional Development and EuropeanUnion Funds. Development index . [cited 2018 Jun 21]. Available at: https
Bozidar Casar, Maria do Carmo Lopes, Advan Drljević, Eduard Gershkevitsh and Csilla Pesznyak
rationales behind the recommendations as well as to limited extent also legislative backgrounds, mostly within recently published international documents and basic safety standards (BSS) – EuropeanUnion Council Directive 2013/59/EURATOM (EU BSS Directive), European Commission RP 174 European Guidelines for Medical Physics Experts (EC RP 174), IAEA Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards (IAEA IBSS) and IAEA Human Health Series No. 25, Roles and Responsibilities, and Education and Training Requirements for Clinically
Lučka Debevec, Tina Jerič, Viljem Kovač, Marko Bitenc and Miha Sok
Debevec L, Debeljak A, Eržen J, Kovač V, Kern I. Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia. Radiol Oncol 2005; 39 : 115-21.
UICC International Union Against Cancer. TNM classification of malignant tumours. Sobin LH, Wittekind CH, editors, Sixth edition. New York: Wiley-Liss; 2002. p. 99-103.
Debevec L, Erzen J, Debeljak A, Crnjac A, Kovac V. Exploratory thoracotomy and its influence on the survival of
Sabine Fromm, Andrea Rottenfusser, Daniel Berger, Robert Pirker, Richard Pötter and Boris Pokrajac
, Koch R, Strelocke K, Paul U. CHARTWEL-Bronchus (ARO 97-1): a randomized multicenter trial to compare conventional fractionated radiotherapy with CHARTWEL radiotherapy in inoperable non-small-call bronchial carcinoma. Strahlenther Onkol 1997; 173 : 663-7.
Ferlay, J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer incidence, Mmortality and prevalence in the EuropeanUnion 1997. Version 4.0. IARC Cancer Base No. 4. Lyon: IARC; 1999.
Bray F, Tycynski JE, Parkin DM. Going up or coming down? The changing phases of lung
Vesna Zadnik, Maja Primic Zakelj, Katarina Lokar, Katja Jarm, Urska Ivanus and Tina Zagar
Institute of Public Health of the Republic of Slovenia 2008 279 96
10 Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the EuropeanUnion: a population-based cost analysis. Lancet Oncol 2013; 14 : 1165-74. 10.1016/S1470-2045(13)70442-X 10.1016/S1470-2045(13)70442-X
Luengo-Fernandez R Leal J Gray A Sullivan R Economic burden of cancer across the EuropeanUnion: a population-based cost analysis Lancet Oncol 2013 14 1165 1165 10.1016/S1470-2045(13)70442-X
11 Ministry of Health RS. Slovene national cancer
. European Commission European guidelines on quality criteria for diagnostic reference levels in thirty-six european countries Luxembourg 1996
2 EuropeanUnion. Diagnostic Reference Levels in Thirty-six European Countries. Part 272. Radiat Prot 2014; 180 : 1-73. EuropeanUnion. Diagnostic Reference Levels in Thirty-six European Countries Part 272. Radiat Prot 2014 180 1 73
3 Mekis N, Zontar D, Skrk D. The effect of breast shielding during lumbar spine radiography. Radiol Oncol 2013; 47 : 26-31. 10.2478/raon-2013-0004 Mekis N Zontar D Skrk D
Dominika Novak Mlakar, Tatjana Kofol Bric, Ana Lucija Škrjanec and Mateja Krajc
Colorectal cancer is a major public health problem in developed world. In 2012, it was the third most common cancer in the world with 1.4 million new cases and was responsible for 8.5% of all cancer-related deaths. 1 In Slovenia, the average incidence of colorectal cancer in the period 2009-2013 was 1,569 cases per year. Incidence rate was higher in men (92.4/100,000) than in women (60.8/100,000). It was the third most common cancer and was responsible for 13.6% of all cancer-related deaths. 2
In 2003, Council of the EuropeanUnion proposed
–6 months after evaluating the initial tumor response. The cause of death was determined as lung cancer when patients had local recurrence or metastases and no other causes of death except for cancer, were presented. Toxicities were evaluated using the Radiation Therapy Oncology Group and European Organization for Research and Treatment of Cancer criteria. 19 The following dosimetric factors were examined with the use of a dose volume histogram of the lung minus the GTV and heart: mean lung dose, lung V5 (lung irradiated 5 Gy [RBE]), lung V10, lung V15, lung V20, and
Tadej Dovšak, Alojz Ihan, Vojislav Didanovič, Andrej Kansky and Nataša Hren
Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the EuropeanUnion: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33: 1075-107.
Forastiere A, Koch W, Trotti A, Sidransky D. Head and Neck Cancer. N Engl J Med 2001; 345: 1890-900.
Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol 2009; 45: 201
Lei Du, Xin Xin Zhang, Lin Chun Feng, Jing Chen, Jun Yang, Hai Xia Liu, Shou Ping Xu, Chuan Bin Xie and Lin Ma
2014-048-01, and all eligible patients provided informed consent in written form.
Inclusion criteria were as follows: histologically proven type I and II NPC according to World Health Organization (WHO) criteria; stage I–IVa according to the Union for International Cancer Control (UICC) 2002 Staging System; aged between 15 and 75 years; Karnofsky performance status score ≥ 70; white blood cell count ≥ 3,500/μL, platelet count ≥ 100,000/μL, serum creatinine concentration < 133 umol/L, and liver transaminase level < 2.0 times of the upper normal value. Exclusion